篇名 | A Case of Refractory T‑cell Lymphoblastic Lymphoma Coexisting with ZMYM2‑Fibroblastic Growth Factor Receptor‑1 Fusion‑Related Myeloproliferative Disease and Review of Literatures |
---|---|
卷期 | 42:1 |
作者 | Tsung‑Ying Yu 、 Tzu‑Chuan Huang 、 Yi‑Ying Wu |
頁次 | 050-052 |
關鍵字 | T‑cell lymphoblastic lymphoma 、 myeloproliferative disease 、 ZMYM2‑fibroblastic growth factor receptor‑1 fusion gene 、 allogeneic hematopoietic stem cell transplantation 、 MEDLINE 、 Scopus |
出刊日期 | 202202 |
DOI | 10.4103/jmedsci.jmedsci_230_21 |
T‑cell LBL (T‑LBL) is a rare lymphoma subtype in adults, and it usually has a dismal prognosis compared to other subtypes of non‑Hodgkin lymphoma. Here, we present a unique case of T‑LBL with myeloproliferative disease. A distinct fusion gene of ZMYM2‑FGFR1 translocation was detected through next‑generation sequencing, and this might be correlated with the translocation of chromosomes 8 and 13 (t[8;13]). Her disease condition seemed to be refractory to multiple lines of chemotherapy. Her lymphoma finally achieved a complete remission after a matched related allogeneic hematopoietic stem cell transplantation.